Explored better ways to manage treatment-related toxicities
Acceptance Speech
Charles L. Loprinzi, MD, is the Regis Professor of Breast Cancer Research,
emeritus chair of the Division of Medical Oncology, and emeritus vice chair
of the Department of Oncology, Mayo Clinic. His work and accomplishments
include:
Research that generated preliminary data about the benefit of minocycline
for the prevention of chemotherapy-induced neuropathy so
that larger studies could be planned
Focuses on studies of cancer-related problems such as cancer
anorexia and cachexia, and the management of hot flashes among
cancer survivors
From 2000 through 2010, served as founding editor for the “Art of
Oncology” department in the Journal of Clinical Oncology, and edited
two anthologies of articles from the “Art of Oncology” series (available
in Kindle electronic book format)
Served as the principal investigator of the North Central Cancer
Treatment Group, Community Clinical Oncology Program (CCOP)
research base for more than a decade
Recipient of numerous awards, including the Komen Foundation
Brinker Award in 2002, the 2005 Komen Foundation Professor of
Survivorship Award, and the 2006 Clinical Research Award from
the Association of Community Cancer Centers